Sort   by:  
 Page size 
Multiple myeloma (MM) is an incurable hematological malignancy characterized by the uncontrolled growth of plasma cells in the bone marrow. The major barrier in treating MM is the occurrence of primary and acquired therapy resistance to multiple existing anti-cancer drugs. Often, this therapy resist...
ORGANISM(S): Homo sapiens 
2021-03-31 | GSE162475 | GEO
As aberrant phosphorylation is a hallmark of tumor cells, the display of tumor-specific phosphopeptides by Human Leukocyte Antigen (HLA) class I molecules can be exploited in the treatment of cancer by T-cell-based immunotherapy. Yet, the characterization and prediction of HLA-I phospholigands is ch...
ORGANISM(S): Homo sapiens (Human) 
2016-12-12 | PXD005084 | Pride
HLA class I molecules bind peptides derived from the intracellular degradation of endogenous proteins and present them to cytotoxic T lymphocytes, allowing the immune system to detect transformed or virally infected cells. It is known that endogenous HLA class I associated peptides may harbor posttr...
ORGANISM(S): Homo sapiens (Human) 
2014-02-03 | PXD000450 | Pride
RNA sequencing reveals that withaferin A reduces overexpression of Bruton's tyrosine kinase in glucocorticoid resistant multiple myeloma cells
Sort   by:  
 Page size